Transplant center directory

Transplant is a time of great challenge and great hope. At University of Minnesota Medical Center & University of Minnesota Masonic Children's Hospital, our blood & marrow transplant team offers superior clinical treatment along with compassionate and personalized patient care. Our physicians provide Autologous & Allogeneic transplant options for malignant and non-malignant disease including many rare genetic conditions. We have extensive expertise with different stem cell sources and conditioning intensities tailored to the patient's disease risk and tolerance for intense therapy. The world's first successful matched, related donor bone marrow transplant was performed in 1968 at our center. Our extensive history allows us to provide specialized treatment options for patients including those with high risk, relapsed, & refractory disease. To date, our physicians have performed over 8,000 BMTs. Our adult & the pediatric hospitals are authorized centers for the FDA approved CAR-Therapies

This center has been performing allogeneic transplants since 1968 and has been an NMDP/Be The Match transplant center since May 1988.

University of Minnesota Blood and Marrow Transplant Program - Adults

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 254 patients.

The actual 1-year survival of these patients is 77.1%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.2% and 83.1%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

University of Minnesota Blood and Marrow Transplant Program - Pediatrics

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 134 patients.

The actual 1-year survival of these patients is 83.4%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 81.3% and 92.4%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.